Некоторое содержание этого приложения в настоящий момент недоступно.
Если эта ситуация сохраняется, свяжитесь с нами по адресуОтзывы и контакты
1. (TN2016000528) .

Ведомство : Тунис
Номер заявки: 2016000528 Дата заявки: 10.06.2015
Номер публикации: 2016000528 Дата публикации: 04.04.2018
Вид публикации: A1
Справочный номер PCT: Номер заявки:PCTEP2015062993 ; Номер публикации: Нажать здесь, чтобы просмотреть данные
Заявители:
Изобретатели:
Дата приоритета:
Название: (FR) .
Реферат:
(FR)

<p>The invention relates to antibodies directed against CD127, the alpha chain of the interleukin 7 (IL-7) receptor IL-7R), and which have antagonist properties for IL-7-IL-7R interaction, may present cytotoxic activity against CD127 positive cells but do not increase the maturation of dendritic cells (DCs) induced by TSLP, a cytokine also using CD127 as part of its receptor. Alternatively, or in addition, these antibodies do not induce the internalization of CD127 and/or inhibit the IL7-induced internalization of CD127. According to another aspect of the invention antibodies are provided which recognize a human CD127 epitope comprising sequences from the 2b site of CD127, in particular the epitope comprising comprises the human CD127 sequences of domain D1 and of the 2b site of CD127, in particular the epitope comprises at least one sequence from D1 comprising SEQ ID No: 115 (in particular comprising SEQ ID No: 10) and/or SEQ ID No: 111 and / or a sequence from the 2b site comprising the sequence of SEQ ID No: 116 and optionally also comprises SEQ ID No: 117 (in particular comprises SEQ ID No: 111).The antibodies of the invention are suitable for use inorder to remedy to a condition diagnosed in a human patient which results from pathogenesis related to lymphopoiesis, when IL-7 signalling pathways provide contribution to said pathogenesis, especially when an increase in the maturation, more precisely the upregulation of costimulatory molecules, of dendritic cells is undesirable.</p>


Также опубликовано как:
UAa201613258SG11201610036PCA2950823AU2015273532EP3155014KR1020170019417
US20170129959IL249449CN106715471VN52585MYPI 2016002094PH1/2016/502445
JP2017522903TH171839IN201617042413BR112016028755EA201692460RU2016151265
CR20160576WO/2015/189302